Regulus Therapeutics Inc. (RGLS) Declined -5.19% or -0.07 To Price $1.28 On Wednesday


Regulus Therapeutics Inc. (RGLS) declined -5.19% or -0.07 to $1.28. It is close to 929265 shares traded, which is 118.11% compare to the average total volume 786812. The market cap of RGLS is $133.06 million. The year to date change is 19.47%. The 52 week price range is from $0.79 to $2.3. Price of RGLS have changed 2.27% during last week. It have changed 29.81% over last month, 15.38% over last 3 months, 22.73% over last 6 months and -40.00% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for RGLS is 1.03. It is -19.53% below current price. The 200-day Moving Averages for RGLS is 1.17. It is -8.59% below current price. The 52-week High is 2.3. It is 79.69% from the current price. The 52-week Low is 0.79. It is -38.28% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of RGLS is 2.91 on 2017-12-29. Short % to float is 2.01%. There are some statistics of RGLS. It is has market cap $133.06 million. The share outstanding is 103.96 million. The average volume is 786812. The revenue is 72000. The percent of top 15 Institution holding is 69.10%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of RGLS is -127.78%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of RGLS is -74.82%.


Tags:

Share this post